13F Holdings
中文EN

EVH Evolent Health, Inc.

Services-Management Services · NYSE · SEC CIK 1628908 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.1%
TTM net income YoY-296.1%
TTM EPS YoY-187.3%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR—

Margins

Gross margin15.0%
Operating margin-18.5%
Net margin-21.7%
FCF margin—
EBITDA margin-13.9%

Returns

ROE-83.6%
ROA-23.0%
ROIC (approx.)-23.0%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets81.0%
Debt / equity2.60x
Current ratio1.26x
Interest coverage-6.23x

Cash quality & payout

Operating cash flow / net income-0.13x
Accruals ratio-25.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.88B$2.55B$1.96B$1.35B$907.96M
Cost of revenue$1.48B$2.19B$1.50B$1.04B$657.55M
Gross profit$399.88M$367.35M$460.47M$316.58M$250.41M
R&D expense————$15.50M
SG&A expense$303.87M$263.05M$358.11M$269.27M$219.50M
Operating income-$410.14M-$40.48M-$71.21M$3.64M-$42.41M
Interest expense$57.47M$24.72M$54.20M$15.57M$25.43M
Pretax income-$534.64M-$63.04M-$202.41M-$62.08M-$29.80M
Income tax-$126,000-$1.41M-$89.36M-$43.38M$483,000
Net income-$534.51M-$61.62M-$113.04M-$19.16M-$37.60M
EBITDA-$294.29M$77.89M$52.20M$70.84M$17.63M
EPS (basic)-5.07-0.81-1.28-0.20-0.44
EPS (diluted)-5.07-0.81-1.28-0.20-0.44
Weighted avg. shares (diluted)114.21M114.68M111.25M93.70M86.07M
Balance sheet
Cash & equivalents$151.86M$178.50M$223.46M$215.16M$354.94M
Receivables$309.86M$414.68M$446.75M$254.68M$130.60M
Current assets$506.37M$607.12M$683.67M$478.05M$523.96M
PP&E, net$80.78M$73.15M$78.19M$87.87M$81.36M
Goodwill$694.48M$1.14B$1.12B$722.77M$426.30M
Intangibles$584.94M$680.16M$752.01M$442.78M$279.78M
Total assets$1.90B$2.54B$2.68B$1.82B$1.42B
Current liabilities$385.26M$715.50M$674.24M$433.44M$445.49M
Short-term debt$0$171.47M$0$0$0
Long-term debt$970.54M$490.52M$597.05M$412.99M$215.68M
Total debt$970.54M$661.99M$597.05M$412.99M$215.68M
Total liabilities$1.48B$1.35B$1.43B$957.88M$725.83M
Shareholders' equity$415.19M$1.00B$1.07B$859.42M$693.63M
Net debt$818.68M$483.49M$373.59M$197.83M-$139.27M
Cash flow statement
Operating cash flow$38.84M$18.77M$142.58M-$11.55M$38.75M
Investing cash flow-$233,000-$62.93M-$415.54M-$259.12M-$15.79M
Financing cash flow-$35.92M-$565,000$281.34M$131.54M-$29.55M
Depreciation & amortization$115.85M$118.37M$123.42M$67.19M$60.04M
Stock-based compensation$39.74M$39.75M$40.50M$33.98M$16.71M
Share buybacks$40.00M$0$0——

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.